COVID-19 and endocrine disorders: a potential new trigger
Minerva Med
.
2023 Dec;114(6):767-769.
doi: 10.23736/S0026-4806.23.08936-X.
Epub 2023 Oct 6.
Authors
Xavier Capó
1
,
Giuseppe Annunziata
2
,
Manuel Jiménez-Garcia
3
4
,
Giovanna Muscogiuri
5
6
,
Luigi Barrea
7
Affiliations
1
Translational Research in Aging and Longevity (TRIAL) Group, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
2
Department of Experimental Medicine, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy.
3
Group of Neurophysiology, Department of Biology, Faculty of Science, University of the Balearic Islands, Palma, Spain - manuel.jimenez@uib.cat.
4
Group of Neurophysiology, Behavioral Studies and Biomarkers, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
5
Unit of Endocrinology, Diabetology and Andrology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
6
Cattedra Unesco "Educazione alla Salute e allo Sviluppo Sostenibile", University of Naples Federico II, Naples, Italy.
7
Dipartimento di Scienze Umanistiche, Università Telematica Pegaso, Naples, Italy.
PMID:
37800449
DOI:
10.23736/S0026-4806.23.08936-X
No abstract available
MeSH terms
COVID-19*
Endocrine System Diseases* / complications
Humans
SARS-CoV-2